miR-24 Alleviates MI/RI by Blocking the S100A8/TLR4/MyD88/NF-kB Pathway. Yang J, Xiang Z, Zhang J, Yang J, et al. J Cardiovasc Pharmacol 2021;78:847-857.

Read + Share

Amedeo Smart

Independent Medical Education

Yang J, Xiang Z, Zhang J, Yang J, et al. miR-24 Alleviates MI/RI by Blocking the S100A8/TLR4/MyD88/NF-kB Pathway. J Cardiovasc Pharmacol 2021;78:847-857.
PMID: 34581696